简介：
Overview
This article describes the implementation of an orthotopic model of renal cell carcinoma in immunocompetent mice, allowing for the study of tumor growth and metastasis. The model includes a primary renal tumor and lung metastases, providing a clinically relevant system for preclinical treatment testing.
Key Study Components
Area of Science
- Urologic oncology
- Cancer metastasis
- Preclinical models
Background
- Renal cell carcinoma is a common type of kidney cancer.
- Understanding tumor growth and metastasis is crucial for developing effective therapies.
- Orthotopic models mimic the natural progression of cancer.
- This study focuses on a method for establishing these models in mice.
Purpose of Study
- To establish mouse orthotopic renal tumors for research.
- To evaluate the efficacy of anti-tumor therapies.
- To provide insights into the mechanisms of kidney cancer progression.
Methods Used
- Intrarenal implantation of Renca tumor cells.
- Cell culture detachment using 0.25% Trypsin and HBSS.
- Centrifugation and re-suspension of cells in fresh HBSS.
- Monitoring tumor growth and metastasis in vivo.
Main Results
- Successful establishment of primary renal tumors in mice.
- Observation of lung metastases mimicking clinical scenarios.
- Evaluation of treatment responses in the preclinical model.
- Insights into the effectiveness of novel therapies.
Conclusions
- The orthotopic model is a valuable tool for studying renal cell carcinoma.
- This method enhances the understanding of tumor biology and treatment efficacy.
- Future studies can leverage this model for therapeutic development.
What is the significance of using an orthotopic model?
It closely mimics the clinical progression of renal cell carcinoma, providing relevant insights for treatment testing.
How are the Renca tumor cells prepared?
Cells are detached with Trypsin, neutralized, centrifuged, and re-suspended in HBSS.
What are the advantages of this model?
It allows for the study of both primary tumors and metastases in the same animal, reflecting clinical scenarios.
Can this model be used for testing novel therapies?
Yes, it is designed to evaluate the efficacy of new anti-tumor treatments in a preclinical setting.
What type of mice are used in this study?
Immunocompetent mice are used to better mimic human immune responses to tumors.
What key questions can this model help answer?
It can help determine the effectiveness of therapies and understand tumor growth dynamics.
繁體中文
